Similar articles

• Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

  Ellinger LK, Ipema HJ, Stachnik JM. Ellinger LK, et al. Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16. Ann Pharmacother. 2010. PMID: 20233913 Review.
• Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.

  Lin YH, Liu CY, Hsiao MC. Lin YH, et al. Psychiatry Clin Neurosci. 2005 Oct;59(5):613-5. doi: 10.1111/j.1440-1819.2005.01424.x. Psychiatry Clin Neurosci. 2005. PMID: 16194268
• Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.

  Chandradasa M, Champika L, de Silva S, Kuruppuarachchi KALA. Chandradasa M, et al. Trials. 2017 Sep 20;18(1):435. doi: 10.1186/s13063-017-2162-6. Trials. 2017. PMID: 28931411 Free PMC article. Clinical Trial.
• Strategies to control antipsychotic-induced weight gain.

  Kapoor S. Kapoor S. Psychoneuroendocrinology. 2008 Sep;33(8):1171. doi: 10.1016/j.psyneuen.2008.04.008. Epub 2008 Jul 22. Psychoneuroendocrinology. 2008. PMID: 18650021 No abstract available.
• Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.

  Newall H, Myles N, Ward PB, Samaras K, Shiers D, Curtis J. Newall H, et al. Int Clin Psychopharmacol. 2012 Mar;27(2):69-75. doi: 10.1097/YIC.0b013e32834d0a5b. Int Clin Psychopharmacol. 2012. PMID: 21979790 Review.